Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Reccan AB logo — A breakthrough in the detection of pancreatic cancer

Reccan AB

A breakthrough in the detection of pancreatic cancer

Founded 2014 Sweden Sweden 3 employees Series Unknown Health Care

General Information

Company Name Reccan AB
Founded Year 2014
Location Sweden Sweden +1
Employees 3
Industries Health Care
Funding Stage Series Unknown
Social

Get notified when Reccan AB moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Reccan AB

Reccan AB, a health tech startup founded in 2014 in Sweden, has been making waves in the medical industry with its breakthrough in the detection of pancreatic cancer. With the slogan "A breakthrough in the detection of pancreatic cancer," the company aims to improve the prognosis for patients diagnosed with this deadly disease. Reccan is dedicated to pioneering early diagnosis, believing it is the key to a better prognosis for pancreatic cancer patients. The company's vision is clear: setting a standard for early detection of pancreatic cancer to save lives. By finding the cancer at an earlier stage than currently possible, Reccan is working towards changing the trajectory of pancreatic cancer mortality. Early detection not only provides a better chance for effective interventions but also enhances the effectiveness of treatments. The most recent milestone for Reccan occurred with its Venture Round investment on 08 September 2020, with LU Innovation as the primary investor. This marks a significant step for the company as it strives to bring its vision to fruition and make a tangible impact in the realm of medical technology. With a promising outlook and a clear focus on addressing a critical health issue, Reccan AB is a company to watch in the coming years.

Taxonomy: medtech, pancreatic cancer, early detection, prognosis improvement, diagnostic technology, solid cancer, tumor-specific treatment, cancer mortality, medical innovation, oncology, patient prognosis, early intervention, medical advancements

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 08 Sep 2020

Reccan AB Alternatives & Competitors

Reccan AB vs
Epi One
Epi One United States

Taking Cancer Diagnosis to the Next Level

Angel
3 employees
Biotechnology, Health Care
Reccan AB vs
Fournier-Majoie Foundation
Fournier-Majoie Foundation Belgium

Empowering entrepreneurs to crush cancer

9 employees
Reccan AB vs
GenoME Diagnostics Ltd
GenoME Diagnostics Ltd United Kingdom

Improving the ovarian cancer diagnostic pathway through earlier and more accurate diagnosis.

Seed
5 employees
Health Care

FAQ About Reccan AB

A breakthrough in the detection of pancreatic cancer
Reccan AB was founded in 2014.
Reccan AB is headquartered in Sweden.
Reccan AB operates in the following industries: Health Care.
Reccan AB has approximately 3 employees.
Reccan AB has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Reccan AB include Epi One, Fournier-Majoie Foundation, GenoME Diagnostics Ltd, Previse, Craif Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Reccan AB and Epi One are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Reccan AB and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy